Ocumetics Technology (TSXV:OTC) ROCE % : -428.27% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Ocumetics Technology ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ocumetics Technology's annualized ROCE % for the quarter that ended in Dec. 2023 was -428.27%.

Ocumetics Technology ROCE % Historical Data

The historical data trend for Ocumetics Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumetics Technology ROCE % Chart

Ocumetics Technology Annual Data

Trend

Jul20

Jul21

Dec22

Dec23

ROCE %

-357.46

-334.55

-468.74

Ocumetics Technology Quarterly Data
	Jul20	Jul21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial						-155.54	-232.09	-706.27	-414.53	-428.27

Ocumetics Technology ROCE % Calculation

Ocumetics Technology's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-3.614	/	( ( (1.374 - 0.244)	+	(1.036 - 0.624) )	/ 2 )
	=	-3.614	/	( (1.13	+	0.412)	/ 2 )
	=	-3.614	/	0.771
	=	-468.74 %

Ocumetics Technology's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-2.848	/	( ( (1.304 - 0.386)	+	(1.036 - 0.624) )	/ 2 )
	=	-2.848	/	( ( 0.918	+	0.412 )	/ 2 )
	=	-2.848	/	0.665
	=	-428.27 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Ocumetics Technology (TSXV:OTC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ocumetics Technology ROCE % Related Terms

Thank you for viewing the detailed overview of Ocumetics Technology's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumetics Technology (TSXV:OTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ocumetics Technology Corp (TSXV:OTC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

OTCFF:USA

Address

639 - 5th Avenue S.W., Suite 1250, Calgary, AB, CAN, T2P 0M9

Website

https://www.ocumetics.com

Ocumetics Technology Corp is a Canadian-based research and product development company. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses, especially for people over 45 years of age.

Executives

Roger Jewett

Director, Senior Officer

Ocumetics Technology (TSXV:OTC) Headlines

No Headlines